Gene · 60489
Papers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,812
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base. | Turk J Chem | 2022 | 37529731 | PubTator, text mining | PubMed |
| Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma. | Cancer Res Commun | 2022 | 36970060 | PubTator, text mining | PubMed |
| Genomic signatures of protease and reverse transcriptase genes from HIV-1 subtype C isolated from first-line ART patients in India. | Bioinformation | 2022 | 36909690 | PubTator, text mining | PubMed |
| Characterizing microRNA editing and mutation sites in Autism Spectrum Disorder. | Front Mol Neurosci | 2022 | 36743290 | PubTator, text mining | PubMed |
| The emerging role of exosomes in innate immunity, diagnosis and therapy. | Front Immunol | 2022 | 36726968 | PubTator, text mining | PubMed |
| Molecular insights into onset of autoimmunity in SARS-CoV-2 infected patients. | Rheumatol Autoimmun | 2022 | 36714799 | PubTator, text mining | PubMed |
| Many Ways to Communicate-Crosstalk between the HBV-Infected Cell and Its Environment. | Pathogens | 2022 | 36678377 | PubTator, text mining | PubMed |
| Characterizing Relevant MicroRNA Editing Sites in Parkinson's Disease. | Cells | 2022 | 36611869 | PubTator, text mining | PubMed |
| Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy. | J Virus Erad | 2022 | 36582472 | PubTator, text mining | PubMed |
| Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners. | Chin Med J (Engl) | 2022 | 36574218 | PubTator, text mining | PubMed |
| APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma. | Heliyon | 2022 | 36568653 | PubTator, text mining | PubMed |
| An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. | Sci Adv | 2022 | 36563152 | PubTator, text mining | PubMed |
| High APOBEC3B mRNA Expression Is Associated with Human Papillomavirus Type 18 Infection in Cervical Cancer. | Viruses | 2022 | 36560657 | PubTator, text mining | PubMed |
| Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods. | Biomolecules | 2022 | 36551164 | PubTator, text mining | PubMed |
| Historic and Prehistoric Epidemics: An Overview of Sources Available for the Study of Ancient Pathogens. | Epidemiologia (Basel) | 2022 | 36547255 | PubTator, text mining | PubMed |
| Silent codon positions in the A-rich HIV RNA genome that do not easily become A: Restrictions imposed by the RNA sequence and structure. | Virus Evol | 2022 | 36533144 | PubTator, text mining | PubMed |
| Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals. | Front Immunol | 2022 | 36532041 | PubTator, text mining | PubMed |
| Interferon and interferon-stimulated genes in HBV treatment. | Front Immunol | 2022 | 36531993 | PubTator, text mining | PubMed |
| Efficient production of protein complexes in mammalian cells using a poxvirus vector. | PLoS One | 2022 | 36520869 | PubTator, text mining | PubMed |
| The emerging role of DEAD/H-box helicases in hepatitis B virus infection. | Front Cell Infect Microbiol | 2022 | 36506030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60489/papers?page=18